NEWS

Pharmaceutical Industry news helps our clients to give competitive edge to their customers and also latest pharmaceutical industry news assists them in gaining updated knowledge. We bring you Global Pharmaceutical news about acquisitions, project undertakings, business and marketing, subjects, and industry related subjects, written in a professional, unbiased and thought-provoking format. Our international pharmaceutical News will help you enhance your business knowledge and productivity.

news

Cosmo Pharmaceuticals NV Says Remimazolam successfully concludes phase iii clinical trial for procedural sedation in bronchoscopy. Says primary efficacy endpoint successfully achieved. Says excellent safety profile of Remimazolam confirmed.   Source: reuters.com

news

Vectura Group Plc said on Wednesday it has signed an exclusive deal with Sandoz AG, a unit of Swiss drugmaker Novartis, to develop a generic copy of an existing combined lung therapy for the U.S. market. British drugmaker Vectura has been trying to build a specialized lung drug business since…

news

Investors in drugmaker AstraZeneca have taken defensive positions in the options market ahead of eagerly awaited results of a major trial of a lung cancer treatment, which are due any day now. The British group is hoping to secure a substantial slice of a multibillion-dollar market by proving its combination…

news

Merck & Co said on Tuesday its experimental cholesterol drug from a class with a history of consistent failure lowered deaths and heart attacks in a large trial, but the company has yet to decide whether to seek approval despite the surprise success. The drugmaker reported only that the drug,…

news

Zosano Pharma announces outcome of end of phase 2 meetings with FDA. Zosano Pharma - Received confirmation, a single efficacy study, our recently completed Zotrip trial, is sufficient to support an NDA filing for M207. Zosano Pharma - FDA concurred that development strategy, which conforms to relevant regulatory guidelines, appears…

news

Zydus Cadila has received the final approval from the USFDA to market Entecavir Tablets in the strengths of 0.5 mg and 1 mg. The drug is used in the treatment of Hepatitis B Virus infection and will be produced at the group’s formulations manufacturing facility at the Pharma SEZ in…

news

The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surgery. The news sent Portola's shares up as much as 51 percent to $57.90. The drug,…

news

Zogenix Inc - on June 22 U.S. FDA granted its investigational drug, ZX008 orphan drug designation for treatment of Lennox Gastaut Syndrome. Zogenix Inc - intends to initiate Phase 3 clinical trial in LGS in second half of 2017 - SEC filing. Zogenix Inc - company expects that first patients…

news

U.S. health regulators on Thursday approved a new formulation of Roche's big-selling cancer drug Rituxan for three common types of blood cancers that allows for relatively quick administration via injection under the skin in place of a lengthy intravenous infusion, the company said. The new formulation, to be sold under…

news

Cardiome announces licensing agreement for xydalba™ (dalbavancin hydrochloride) to support planned commercialization in Israel. Cardiome Pharma Corp - signed an exclusive license and distribution agreement with tzamal medical ltd. Cardiome Pharma Corp - tzamal will be responsible for obtaining regulatory and pricing approvals for xydalba from israel's ministry of health.…

loadmore..